IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis

被引：199

作者：

Siersbaek, Rasmus ^{[1
,10
]}

Scabia, Valentina ^{[2
]}

Nagarajan, Sankari ^{[1
]}

Chernukhin, Igor ^{[1
]}

Papachristou, Evangelia K. ^{[1
]}

Broome, Rebecca ^{[1
]}

Johnston, Simon J. ^{[3
,11
]}

Joosten, Stacey Ep ^{[4
]}

Green, Andrew R. ^{[3
]}

Kumar, Sanjeev ^{[1
,5
]}

Jones, Julia ^{[1
]}

Omarjee, Soleilmane ^{[1
]}

Alvarez-Fernandez, Ruben ^{[1
]}

Glont, Silvia ^{[1
]}

Aitken, Sarah J. ^{[1
,6
,7
]}

Kishore, Kamal ^{[1
]}

Cheeseman, Danya ^{[1
]}

Rakha, Emad A. ^{[3
]}

D'Santos, Clive ^{[1
]}

Zwart, Wilbert ^{[4
,8
,9
]}

Russell, Alasdair ^{[1
]}

Brisken, Cathrin ^{[2
]}

Carroll, Jason S. ^{[1
]}

机构：

[1] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 ORE, England

[2] Ecole Polytech Fed Lausanne EPFL, ISREC Swiss Inst Expt Canc Res, Sch Life Sci, CH-1015 Lausanne, Switzerland

[3] Univ Nottingham, Nottingham Breast Canc Res Ctr, Sch Med, Div Canc & Stem Cells,Biodiscovery Inst, Univ Pk, Nottingham NG7 2RD, England

[4] Netherlands Canc Inst, Oncode Inst, Div Oncogen, Amsterdam, Netherlands

[5] Addenbrookes Hosp, Cambridge CB2 0QQ, England

[6] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Histopathol, Cambridge CB2 0QQ, England

[7] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England

[8] Eindhoven Univ Technol, Dept Biomed Engn, Lab Chem Biol, Eindhoven, Netherlands

[9] Eindhoven Univ Technol, Dept Biomed Engn, Inst Complex Mol Syst, Eindhoven, Netherlands

[10] Univ Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark

[11] AstraZeneca, Translat Med, Cambridge CB2 0AA, England

来源：

CANCER CELL | 2020年 / 38卷 / 03期

基金：

英国惠康基金;

关键词：

ENDOTHELIAL GROWTH-FACTOR; ER-ALPHA; INTERLEUKIN-6; IL-6; STAT3; TRANSCRIPTION; DETERMINANT; RESISTANCE; CYTOKINE; DATABASE;

D O I：

10.1016/j.ccell.2020.06.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The cytokine interleukin-6 (IL6) and its downstream effector STAT3 constitute a key oncogenic pathway, which has been thought to be functionally connected to estrogen receptor alpha (ER) in breast cancer. We demonstrate that IL6/STAT3 signaling drives metastasis in ER+ breast cancer independent of ER. STAT3 hijacks a subset of ER enhancers to drive a distinct transcriptional program. Although these enhancers are shared by both STAT3 and ER, IL6/STAT3 activity is refractory to standard ER-targeted therapies. Instead, inhibition of STAT3 activity using the JAK inhibitor ruxolitinib decreases breast cancer invasion in vivo, Therefore, IL6/STAT3 and ER oncogenic pathways are functionally decoupled, highlighting the potential of IL6/STAT3-targeted therapies in ER+ breast cancer.

引用

页码：412 / +

页数：21

共 50 条

[21] Converging purinergic and immune signaling pathways drive IL-6 secretion by Fragile X cortical astrocytes via STAT3 [J].

Reynolds, Kathryn E. ;

Krasovska, Victoria ;

Scott, Angela L. .

JOURNAL OF NEUROIMMUNOLOGY, 2021, 361

[22] IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway [J].

Jiang, Mingfang ;

Wang, Ye ;

Zhang, Hua ;

Ji, Youxin ;

Zhao, Peng ;

Sun, Rongli ;

Zhang, Chunling .

THORACIC CANCER, 2018, 9 (05) :621-629

[23] ISG15 promotes tumor progression via IL6/JAK2/STAT3 signaling pathway in ccRCC [J].

Xie, Wei ;

Zhang, Yuanfeng ;

Zhang, Zhechuan ;

Li, Qinke ;

Tao, Lesha ;

Zhang, Ronggui .

CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)

[24] STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor [J].

Wang, Yuxin ;

van Boxel-Dezaire, Anette H. H. ;

Cheon, HyeonJoo ;

Yang, Jinbo ;

Stark, George R. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (42) :16975-16980

[25] Bone metastasis from breast cancer involves elevated IL-11 expression and the gp130/STAT3 pathway [J].

Ren, Li ;

Wang, Xia ;

Dong, Zuoliang ;

Liu, Jun ;

Zhang, Shiwu .

MEDICAL ONCOLOGY, 2013, 30 (03)

[26] Expression of estrogen receptor alpha increases leptin-induced STAT3 activity in breast cancer cells [J].

Binai, Nadine A. ;

Damert, Annette ;

Carra, Gert ;

Steckelbroeck, Stephan ;

Loewer, Johannes ;

Loewer, Roswitha ;

Wessler, Silja .

INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (01) :55-66

[27] Dystrophy-associated caveolin-3 mutations reveal that caveolae couple IL6/STAT3 signaling with mechanosensing in human muscle cells [J].

Dewulf, Melissa ;

Koster, Darius Vasco ;

Sinha, Bidisha ;

de Lesegno, Christine Viaris ;

Chambon, Valerie ;

Bigot, Anne ;

Bensalah, Mona ;

Negroni, Elisa ;

Tardif, Nicolas ;

Podkalicka, Joanna ;

Johannes, Ludger ;

Nassoy, Pierre ;

Butler-Browne, Gillian ;

Lamaze, Christophe ;

Blouin, Cedric M. .

NATURE COMMUNICATIONS, 2019, 10 (1)

[28] GPER mediates the IL6/JAK2/STAT3 pathway involved in VEGF expression in swine ovary GCs [J].

Xiao, Longfei ;

Wang, Zihui ;

Lu, Ning ;

He, Yanan ;

Qiao, Limin ;

Sheng, Xihui ;

Qi, Xiaolong ;

Xing, Kai ;

Guo, Yong ;

Chang, Di ;

Wang, Xiangguo ;

Zhao, Junjin ;

Deng, Xiaobin ;

Ni, Hemin ;

Kang, Jian .

JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2022, 68 (01) :23-33

[29] Study on expression of IL-6/JAK/STAT3 signaling pathway in category IIIB prostatitis [J].

Li, Guangyu ;

Lan, Haiyan ;

Liang, Jihong ;

Xian, Jing ;

Fang, Dan ;

Mo, Yuncong ;

Zheng, Cheng ;

Dong, Yingjin ;

Li, Yuanfa .

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (04) :3779-3785

[30] CLK3 positively promoted colorectal cancer proliferation by activating IL-6/STAT3 signaling [J].

Ma, Yulin ;

Gao, Fei ;

Liu, Yang .

EXPERIMENTAL CELL RESEARCH, 2024, 440 (01)

← 1 2 3 4 5 →